InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,204.80
(
-0.05%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.21
(
0.87%
)
Bitcoin
61,372.12
(
0.89%
)
Post# of 252393
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 163220

Thursday, 07/11/2013 10:08:17 AM

Thursday, July 11, 2013 10:08:17 AM

Post# of 252393
FDA accepts Eliquis nNDA for primary VTE prevention following hip/knee surgery; PDUFA date is 3/15/14:

http://finance.yahoo.com/news/fda-accepts-eliquis-apixaban-supplemental-113000798.html

Note: The sNDA in primary VTE prevention is separate from the sNDA in VTE treatment and secondary prevention, which is slated for submission to the FDA during the current quarter (#msg-89518539).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up